Cargando…
Corticosteroids as adjunctive therapy in the treatment of coronavirus disease 2019: A report of two cases and literature review
The effect of systemic corticosteroids on clinical outcomes in patients with coronavirus disease 2019 (COVID-19) remains controversial. While the use of corticosteroids raises concerns regarding delayed viral clearance, secondary infections, and long-term complications that can lead to increased mor...
Autores principales: | Kosaka, Makoto, Yamazaki, Yoshitaka, Maruno, Takashi, Sakaguchi, Koji, Sawaki, Shoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480527/ https://www.ncbi.nlm.nih.gov/pubmed/32988730 http://dx.doi.org/10.1016/j.jiac.2020.09.007 |
Ejemplares similares
-
A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction
por: Asano, Yuki, et al.
Publicado: (2021) -
Corticosteroids: A Controversial Therapy for Coronavirus Disease 2019
por: She, Jun, et al.
Publicado: (2020) -
Antivirals With Adjunctive Corticosteroids Prevent Clinical Progression of Early Coronavirus 2019 Pneumonia: A Retrospective Cohort Study
por: Ooi, Say Tat, et al.
Publicado: (2020) -
Adjunctive corticosteroid therapy in patients with pulmonary tuberculosis
por: Lemos, Carolina Xavier, et al.
Publicado: (2022) -
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
por: Danieli, Maria Giovanna, et al.
Publicado: (2021)